| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
GRH-SOMATOSTATIN-GH |
Department of Neuroendocrinology (H.N., K.M., S.H.), Basic Medical Sciences, University of Tsukuba, Tsukuba 305-8575, Japan; Departments of Anatomy (Y.H., S.A., K.K.) and Neurosurgery (M.K.), School of Medicine, Keio University, Tokyo 160-8582, Japan; Laboratory of Functional Anatomy (M.M., E.N., T.H.), Faculty of Agriculture, Meiji University, Kanagawa 214-0071; Japan; Second Department of Internal Medicine (N.H.), National Defense Medical College, Saitama 359-8513, Japan; and Shonan Kamakura General Hospital (S.K.), Kamakura 247-8533, Japan
Address all correspondence and requests for reprints to: Haruo Nogami, Ph.D., Laboratory of Neuroendocrinology, Institute of Basic Medical Sciences, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki 305-8575, Japan. E-mail: . hnogami{at}md.tsukuba.ac.jp
To further elucidate the molecular mechanisms underlying the transcriptional regulation of the GHRH receptor (GHRH-R) gene, hormonal regulation of the promoter activity of this gene was examined. An approximately 3-kb genomic fragment spanning the promoter region of the gene was sequenced and the transcription start site was determined by RT-PCR and RNase protection assay. A major start site was localized at -105 (relative to the translation initiation codon, ATG), and a pit-1 binding sequence characteristic of pituitary specific genes was found at -155 to -146. Deletion and mutation studies demonstrated this site to be functional. In the presence of dexamethasone, the GHRH-R promoter (from -2935 to -11) directed luciferase expression in MtT-S cells, a somatotropic cell line, but not in the PC12 cells that normally do not express GHRH-R. While T3, all trans-RA, and 9cis-RA alone weakly enhanced the reporter gene expression, each of these substances was found to act as a synergistic enhancer in the presence of dexamethasone. Additional deletion and mutation analyses demonstrated a functional RA response element at -1090 to -1074. Two functional glucocorticoid response elements and a T3 response element were found in an 80-bp 5'-flanking sequence of the pit-1 site. Interestingly, it is suggested that the 6-bp half-site AGGACA (from -209 to -204) functions as a 3'-half-site of T3 response element as well as a 5'-half-site of one of the glucocorticoid response elements.
This article has been cited by other articles:
![]() |
A. T. McElvaine, A. I. Korytko, S. M. Kilen, L. Cuttler, and K. E. Mayo Pituitary-Specific Expression and Pit-1 Regulation of the Rat Growth Hormone-Releasing Hormone Receptor Gene Mol. Endocrinol., August 1, 2007; 21(8): 1969 - 1983. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Porter, L. E. Ellestad, A. Fay, J. L. Stewart, and I. Bossis Identification of the Chicken Growth Hormone-Releasing Hormone Receptor (GHRH-R) mRNA and Gene: Regulation of Anterior Pituitary GHRH-R mRNA Levels by Homologous and Heterologous Hormones Endocrinology, May 1, 2006; 147(5): 2535 - 2543. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nogami, Y. Hiraoka, K. Ogasawara, S. Aiso, and S. Hisano The role of pit-1 in the regulation of the rat growth hormone-releasing hormone receptor gene transcription by glucocorticoids J. Mol. Endocrinol., December 1, 2005; 35(3): 477 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ozawa, F. Han, and M. Kawata Exocytosis sensitivity to growth hormone-releasing hormone in subsets of GH cells in rats under different corticosterone conditions. Ultrastructural study using microwave irradiation for fixation and immunocytochemistry J. Endocrinol., December 1, 2004; 183(3): 507 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-L. Fang, S. Shenoy, Z. Duanmu, T. A. Kocarek, and M. Runge-Morris TRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTION Drug Metab. Dispos., November 1, 2003; 31(11): 1378 - 1381. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker International Union of Pharmacology. XXXV. The Glucagon Receptor Family Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |